Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission
Introduction
Introduction
Sexually transmitted diseases (STDs) represent a significant health threat given their potentially serious complications and association with increased transmission of human immunodeficiency virus (HIV). High disease burdens, low diagnosis and treatment rates, and a lack of marketed interventions for the prevention of most STDs highlight the clinical and commercial potential in this area.
Scope
*Review of epidemiology and current treatment practice for chlamydia, gonorrhea, HPV, HSV-2 across the US, Japan, France, Italy, Germany, Spain and UK
*Review of current clinical practice and key drugs and vaccines in development for sexually transmitted diseases
*Thorough assessment of key developments, opportunities and threats shaping the sector
*In-depth discussion of future strategies to improve the management of sexually transmitted diseases
Highlights
The potential for prophylactic vaccines against STDs has been demonstrated by the success of marketed prophylactic human papillomavirus vaccines. Due to its wider serotype coverage, Merck & Co's Gardasil continues to outperform GlaxoSmithKline's Cervarix with annual global sales of $1.7 billion versus $292m, respectively.
Challenges for the development of vaccines against chlamydia, gonorrhea or HSV-2 include vaccine design, considering the complexity of pathogen biology and required immune response, as well as reimbursement and uptake. Successful marketing strategies could exploit the link between STDs and infertility as well as increased HIV transmission.
Improvements in rapid point-of-care diagnostic tests and the development of home-testing devices would increase currently low diagnosis and treatment rates for STDs and help to prevent transmission and long-term complications.
Reasons to Purchase
*Review the epidemiological and clinical factors driving new product decisions in STDs as well as unmet needs with current treatment options.
*Understand challenges, unmet needs and future opportunities by learning about the views of key opinion leaders
*Gain competitive advantage by identifying key product characteristics and potential roles for new therapies
To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/7400/Stakeholder-Opinions-Sexually-Transmitted-Diseases-An-underestimated-threat-lacking-interventions-to-prevent-transmission.html Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission
By: Vision Shopsters
Day 31-34 Crohns Disease Symptoms Diet Treatment Colitis IBS What Are The Physical Symptoms Of Anxiety And How Do You Treat General Anxiety Disorder? Have A Healthy Pregnancy Signs Of Anxiety - How To Get Rid Of Anxiety Symptoms Naturally Digestive Health - Tea And Digestive Health Benefits OCD Symptoms - How to Handle Them Choices For Free Colon Cleanse Making Healthy Meal Plans A Beginner's Guide To Bodybuilding How to Making a Woman Orgasm - 3 Easy Steps to Blow Her Mind With Multiple, Body Shaking Orgasms Herbalife Expert Review - Don't Join Herbalife Until You Read This Finding The Top Body Acne Treatment Products On The Market Losing Pregnancy Weight - Get Your Body Back
www.yloan.com
guest:
register
|
login
|
search
IP(216.73.216.7) California / Anaheim
Processed in 0.017573 second(s), 7 queries
,
Gzip enabled
, discuz 5.5 through PHP 8.3.9 ,
debug code: 37 , 3010, 61,
Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission Anaheim